November 9 - 13, 2005
The Westin Waltham-Boston
Rakesh K. Jain, Massachusetts General Hospital, Boston, MA
Lee M. Ellis, UT M. D. Anderson Cancer Center, Houston, TX
Luisa Iruela-Arispe, University of California, Los Angeles, CA
Nearly 300 researchers and scientists from 20 countries participated in the 2005 AACR Special Conference on Anti-Angiogenesis and Drug Delivery to Tumors: Bench to Bedside and Back. The conference, which was supported by a generous unrestricted educational grant from Genentech BioOncology, featured prominent researchers in the fields of sequencing anti-angiogenic therapy, vascular hypermeability and drug delivery, lymphangiogenesis and lymphatic function, extracellular matrix and drug delivery, targeting pericytes, and the role of EPCs in angiogenesis and delivering therapeutics.
A special NIH-funding session was held on Saturday afternoon, November 12 and opening and closing keynote sessions featured talks from world-reknown leaders in anti-angiogenesis research. Over 80 abstracts were presented during the informal poster sessions on Thursday and Friday afternoons, with several of the highly-rated abstracts presented as short talks during the plenary sessions.
*(Adobe Acrobat Reader required)
Please visit the AACR Meeting Calendar for a complete list of upcoming programs.